Investigation for Investors in Shares of EnteroMedics Inc (NASDAQ:ETRM) Announced

An investigation on behalf of investors in EnteroMedics Inc (NASDAQ:ETRM) shares over potential wrongdoing at EnteroMedics Inc was announced and NASDAQ:ETRM stockholders should contact the Shareholders Foundation.

Logo

San Diego, CA -- (SBWire) -- 03/13/2017 --An investigation on behalf of investors in shares of EnteroMedics Inc was announced over potential breaches of fiduciary duties by certain directors.

Investors who purchased shares of EnteroMedics Inc (NASDAQ:ETRM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain EnteroMedics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Saint Paul, MN based EnteroMedics Inc is a medical device company that is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.

Shares of EnteroMedics Inc (NASDAQ:ETRM) closed on March 10, 2017 at $6.05 per share.

Those who purchased shares of EnteroMedics Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Michael Daniels
General Manager
Shareholders Foundation
858-779-1554
http://www.ShareholdersFoundation.com

View this press release online at: http://rwire.com/781035